Beranda › Kanker Serviks
Uji klinis Kanker Serviks yang merekrut di AS
114 studi untuk Kanker Serviks merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX34 studi
- Nashville, TN19 studi
- New York City, NY19 studi
- Boston, MA18 studi
- Los Angeles, CA16 studi
- Arlington, VA16 studi
- San Antonio, TX14 studi
- St. Louis, MO13 studi
- Dallas, TX13 studi
- Orlando, FL12 studi
- Chicago, IL12 studi
- Columbus, OH11 studi
- Atlanta, GA11 studi
- Baldwin Park, CA11 studi
- Philadelphia, PA10 studi
- San Diego, CA10 studi
- Edison, NJ10 studi
- Cleveland, OH10 studi
- Queens, NY10 studi
- Durham, NC9 studi
- Portland, OR9 studi
- Washington, DC9 studi
- Miami, FL9 studi
- Minneapolis, MN9 studi
- Birmingham, AL8 studi
- Baltimore, MD8 studi
- Rochester, MN7 studi
- New Orleans, LA7 studi
- Seattle, WA7 studi
- Jacksonville, FL7 studi
- Denver, CO7 studi
- Pittsburgh, PA7 studi
- Oklahoma City, OK7 studi
- San Francisco, CA6 studi
- Grand Rapids, MI6 studi
- New Haven, CT6 studi
- Santa Monica, CA6 studi
- Salt Lake City, UT6 studi
- Austin, TX6 studi
- Cincinnati, OH5 studi
Berdasarkan negara bagian
- Alabama9 studi
- Arizona8 studi
- Arkansas3 studi
- California38 studi
- Colorado12 studi
- Connecticut9 studi
- Distrik Columbia5 studi
- Florida29 studi
- Georgia15 studi
- Illinois15 studi
- Indiana5 studi
- Iowa5 studi
- Kansas3 studi
- Kentucky7 studi
- Louisiana8 studi
- Maryland12 studi
- Massachusetts19 studi
- Michigan14 studi
- Minnesota18 studi
- Mississippi3 studi
- Missouri13 studi
- Nebraska4 studi
- Nevada5 studi
- New Jersey13 studi
- New Mexico4 studi
- New York23 studi
- North Carolina14 studi
- Ohio24 studi
- Oklahoma11 studi
- Oregon10 studi
- Pennsylvania15 studi
- Rhode Island4 studi
- South Carolina6 studi
- Tennessee21 studi
- Texas45 studi
- Utah10 studi
- Virginia20 studi
- Washington10 studi
- West Virginia3 studi
- Wisconsin7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06760819Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 1 Okt 2026 · NCT07292818A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT05051722DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT07216703A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 21 Sep 2026 · NCT06925724Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT04038619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07109726PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 17 Sep 2026 · NCT05758688Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05475171Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04723095GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04977453Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06535607Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 10 Sep 2026 · NCT04865887Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06293898Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.